WallStreetZenWallStreetZen

NASDAQ: ASND
Ascendis Pharma A Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Ascendis Pharma A earnings were $855.5M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ASND earnings report on Jun 30, 2026 announced Q2 2026 earnings of $235.2M, down 67.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ASND reported annual earnings of -$268.3M, with -31.9% growth. The next ASND earnings date is Nov 11, 2026.

ASND earnings history

Current Revenue
$1.2B
Current Earnings
$842.9M
Current Profit Margin
70.8%

ASND Return on Equity

Current Company
186.9%
Current Industry
-13.6%
Current Market
30.9%
ASND's Return on Equity (186.9%)... subscribe to Premium to read more.
High Return on Equity Performance

ASND Return on Assets

Current Company
44%
Current Industry
-10.3%
ASND is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ASND announces earnings.

ASND Return on Capital Employed

Current Company
16.92%
Current Industry
-7%
ASND has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ASND vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ASND$375.76M$855.55MN/A$13.70
JAZZ$1.62B$940.76M+68.91%$15.26
EXEL$1.09B$860.62M+60.39%$3.29
SMMT-$855.92M-$856.09MN/A-$0.01
BBIO-$633.10M-$691.87MN/A-$3.56
View Top Biotech Stocks

ASND earnings dates

Next earnings date
Nov 11, 2026

Ascendis Pharma A Earnings Reports & History FAQ

What were Ascendis Pharma A's earnings last quarter?

On ASND's earnings call on Aug 13, 2026, Ascendis Pharma A (NASDAQ: ASND) reported Q2 2026 earnings per share (EPS) of $3.66, up 585.92% year over year. Total ASND earnings for the quarter were $235.19 million. In the same quarter last year, Ascendis Pharma A's earnings per share (EPS) was -$0.75.

If you're new to stock investing, here's how to buy Ascendis Pharma A stock.

When does Ascendis Pharma A report earnings?

The next ASND earnings call is Nov 11, 2026. Add ASND to your watchlist to be reminded of Ascendis Pharma A's next earnings date.

Is Ascendis Pharma A profitable or losing money?

As of the last Ascendis Pharma A earnings report, Ascendis Pharma A is currently profitable. Ascendis Pharma A's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $842.91 million, a 364.24% decrease year over year.

What was ASND's earnings growth in the past year?

As of Ascendis Pharma A's earnings date in Aug 13, 2026, Ascendis Pharma A's earnings has grown year over year. ASND earnings in the past year totalled $855.55 million.

What are Ascendis Pharma A's earnings expectations?

The current EPS estimate for Ascendis Pharma A's earnings report in Nov 11, 2026 is $1.13.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.